Ave vita medicinos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 292,025 | 352,613 | 366,183 | 475,944 | 653,098 | 780,530 | 895,104 | 929,425 |
| Profit before tax | -177,332 | 1,441 | -51,263 | 49,649 | 357,626 | 65,507 | - | 52,693 |
| Net profit | -177,332 | 989 | -51,263 | 49,649 | 348,164 | 61,580 | - | 45,349 |
| Equity | -161,805 | -160,808 | -226,934 | -181,563 | 166,600 | 228,181 | 221,952 | 267,302 |
| Liabilities | 219,533 | 203,172 | 324,781 | 289,268 | 296,668 | 172,924 | 121,074 | 51,992 |
| Non-current assets | 14,481 | 4,931 | 1,459 | 819 | 71,527 | 100,222 | 70,127 | 42,257 |
| Current assets | 43,247 | 37,433 | 96,388 | 106,886 | 391,741 | 300,883 | 272,899 | 277,037 |
| Total assets | 57,728 | 42,364 | 97,847 | 107,705 | 463,268 | 401,105 | 343,026 | 319,294 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 150,444 | 165,136 | 164,527 |
| Social insurance contributions | - | - | - | - | - | 146,468 | 168,888 | 180,899 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +31.4% | +20.7% | +3.8% | +30.0% | +37.2% | +19.5% | +14.7% | +3.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -307.2% | 2.3% | -52.4% | 46.1% | 75.2% | 15.4% | - | 14.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 209.0% | 27.0% | - | 17.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -60.7% | 0.3% | -14.0% | 10.4% | 53.3% | 7.9% | - | 4.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -60.7% | 0.4% | -14.0% | 10.4% | 54.8% | 8.4% | - | 5.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.8 | 0.8 | 0.5 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,685 | 5,467 | 5,392 | 6,603 | 8,836 | 11,204 | 13,067 | 13,454 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ave vita medicinos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-12-30 | 2022-01-13 | 0.04 |
| 2021-11-19 | 2021-12-05 | 0.01 |
Ave vita medicinos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-28 | 2026-07-07 | 18.0 |
| 2024-12-19 | 2025-05-30 | 0.17 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ave vita, UAB (code 300520776) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €929.4K, up 3.8% year on year and 19.1% over two years. Profitability recovered after a weak 2024: net profit reached €45.3K in 2025, compared with a loss of €6.2K in 2024 and a profit of €61.6K in 2023. The 2025 profit margin was 4.9%, below the 2023 level of 7.9% but clearly above the prior year. At year-end 2025, total assets stood at €319.3K, equity at €267.3K and liabilities at €52.0K. Compared with 2024, liabilities declined materially and equity increased, supporting a stronger balance sheet position. The company reported a high equity ratio of 83.7% and a debt-to-equity ratio of 0.19. Return on equity was 17.0% and return on assets 14.2% in 2025. Asset turnover was 2.91x. Revenue per employee was €13.5K, while profit per employee was €657.